Skip to content

Assembly Biosciences ASMB Ratios & Valuation

FY'25FY'24FY'23FY'22
Efficiency
Asset turnover0.4×+0.2×0.2×+0.2×0.1×
Liquidity
Current ratio5.2×+2.8×2.4×-1.0×3.4×-2.5×-3.6×
Quick ratio5.2×+2.8×2.4×-1.0×3.4×-2.5×-3.6×
Cash ratio1.2×+0.4×0.8×+0.3×0.5×-2.7×3.2×+0.4×
Leverage
Debt-to-equity-0.1×0.1×0.0×0.1×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×
Per Share
Book value per share$18.44+232%$5.56-38.1%$8.98-56.2%$20.49+425%
Valuation
Market capitalization$480.77M+262%$100.3M+85.9%$53.96M-14.9%$63.41M-43.1%
Enterprise value$452.14M+302%$65.05M+78.4%$36.46M+152%$14.46M-80.0%
Price / sales6.8×+2.6×3.5×-4.0×7.5×
Price / book2.4×-2.5×+1.7×1.3×+0.5×0.8×+0.1×
EV / sales6.4×+2.9×2.3×-2.8×5.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Assembly Biosciences's ratios come from?
Every ratio is computed from Assembly Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.